Site icon pharmaceutical daily

STATEMENT: Civica Rx Supports Biden Administration Recommendations for Strengthening the Pharmaceutical Supply Chain

LEHI, Utah–(BUSINESS WIRE)–Civica Rx (Civica, Inc.) welcomes the findings of the 100-day supply chain review. The report identifies key vulnerabilities in the generic drug supply chain that contribute to drug shortages and supply risks during a global public health emergency. Among the next steps outlined in the report, we particularly applaud the intent to bolster domestic manufacturing capacity for key products, ensure that reimbursement and procurement policy supports supply chain resilience, and to develop quality maturity ratings that will allow purchasers to recognize quality along with price in procurement decisions.

About Civica Rx

Civica Rx is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related price spikes in the United States. Celebrating its 2nd Anniversary in 2020, Civica is making strides to ensure patients and their needs come first and that essential generic medications are accessible and affordable.

Civica Rx by the Numbers

Learn more at www.civicarx.org or on LinkedIn.

Contacts

Allan Coukell, Government Affairs

Allan.Coukell@civicarx.org
+1 (617) 999-9193

Debbi Ford, Communications

Debbi.ford@civicarx.org
+1 (970) 227-3991

Exit mobile version